A secret plan in the executive suite
When David Joyner, who spent nearly his entire career at CVS and its predecessor companies including Aetna and Caremark, took over in 2024, he vowed to keep the company intact and focus on fixing operations. But this year’s annual planning exercise reached a different verdict: the balance sheet was strong enough to support two independent companies, and a split would create more agile, focused firms.
*“It basically gives you confidence and strength about how each of the businesses are going to perform.” — David Joyner*
The board backed the plan. Aetna and Caremark will form one company, while the roughly 9,000 retail pharmacies will form the other. It is a dramatic reversal of a strategy once expected to cut healthcare costs and improve care by uniting insurance with the legacy pharmacy chain.
From a single store to a $400 billion empire
CVS was founded in 1963 as the Consumer Value Store, selling health and beauty products from a single location in Massachusetts. As healthcare grew, the company rose rapidly and moved into more lucrative sectors: buying Caremark for about $21 billion in 2007, then merging with Aetna in a nearly $70 billion deal in 2018. Executives said at the time that the integrated model would tackle the industry’s two biggest problems, soaring costs and access to care, especially for chronic conditions.

















